contentSlug

type

ContentSlug_ContentQuery

slug

ContentPageContentQuery

content

trendingContent

query ContentSlug_ContentQuery(
  $contentSlug: String!
  $type: [ContentType!]
) {
  ...ContentPageContentQuery_13QmVO
}

fragment CompanyDetails_Content on Content {
  __isContent: __typename
  companies {
    name
    description
    pageUrl
    id
  }
}

fragment CompanyTagList on Company {
  pageUrl
  name
  viewerIsFollowing
}

fragment ContentBasicInfo on Content {
  __isContent: __typename
  id
  type
  title
  lang
  companies {
    ...CompanyTagList
    id
  }
  ...PublishingDetails
  ...Reactions
}

fragment ContentMetadata on Content {
  __isContent: __typename
  type
  title
  lang
  pageUrl
  alternatePageUrls {
    pageUrl
    lang
  }
  imgUrl
  description
  ... on Video {
    liveTime
    videoUrl
  }
  ... on Webcast {
    liveTime
    videoUrl
  }
}

fragment ContentPageContentQuery_13QmVO on Query {
  content(slug: $contentSlug, type: $type) {
    __typename
    id
    type
    title
    isPremium
    lang
    htmlBody
    companies {
      forum {
        latestPosts {
          ...ForumPosts
        }
      }
      defaultInstrument {
        isin
        id
      }
      id
    }
    slug
    ... on CompanyReport {
      reportUrl
    }
    ... on ThirdPartyCompanyReport {
      reportUrl
    }
    ... on StockExchangeRelease {
      reportUrl
    }
    ...ContentBasicInfo
    ...ContentMetadata
    ...PriceAndRecommendation_Content
    ...CompanyDetails_Content
    ...ReportLink_Content
    ...KeyFigures_Content
  }
  ...TrendingContent_1jQ2Cn
}

fragment ForumPosts on ForumPost {
  text
  likesCount
  url
  author
  postedAt
  authorImgUrl
}

fragment KeyFigures_Content on Content {
  __isContent: __typename
  companies {
    defaultInstrument {
      estimateData {
        modelType
        reportingCurrency
      }
      snapshot {
        transaction {
          date
          actualized {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
          estimates {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
        }
      }
      id
    }
    id
  }
}

fragment PriceAndRecommendation_Content on Content {
  __isContent: __typename
  createdAt
  companies {
    id
    name
    viewerIsFollowing
    defaultInstrument {
      snapshot {
        priceData {
          date
          lastPrice
          tradeCurrency
        }
        transaction {
          date
          recommendation
          targetPrice
        }
        prevTransaction {
          recommendation
        }
      }
      id
    }
  }
}

fragment PublishingDetails on Content {
  __isContent: __typename
  createdAt
  publishers {
    name
    imgUrl
  }
  authors {
    __typename
    id
    name
    slug
    imgUrl
    jobTitle
  }
  ... on Video {
    liveTime
  }
  ... on Webcast {
    liveTime
  }
}

fragment Reactions on Content {
  __isContent: __typename
  id
  reactionGroups {
    reactionType
    reactionsCount
    viewerReacted
  }
}

fragment ReportLink_Content on Content {
  __isContent: __typename
  type
  isPremium
  ... on CompanyReport {
    reportUrl
  }
  ... on ThirdPartyCompanyReport {
    reportUrl
  }
  ... on StockExchangeRelease {
    reportUrl
  }
}

fragment TrendingContent_1jQ2Cn on Query {
  trendingContent(type: ARTICLE) {
    __typename
    id
    title
    lang
    pageUrl
    createdAt
    type
    imgUrl
    companies {
      squareLogoUrl
      id
    }
    authors {
      __typename
      imgUrl
      id
    }
    publishers {
      imgUrl
    }
  }
}


optomed-oyj-optomed-plc-managers-transactions-myllyla-2

__typename

title

isPremium

lang

htmlBody

companies

createdAt

publishers

authors

reactionGroups

pageUrl

alternatePageUrls

imgUrl

description

Optomed is a medical technology company. The company conducts research and development of specialized eye cameras. Development takes place of both hardware and software that is resold under different brands. The company operates worldwide, with the largest presence in the Nordic market. The customers consist of research institutes and hospitals. Optomed is headquartered in Oulu.

Forbesissa oli juttu Israelilaisista AI-yhtiöistä, myös AEYE Health jutussa mukana.                   Forbes              In 2024, Israel Became A Global Leader In Applied AI Innovation    Israeli AI startups are making a global impact by developing sector-specific AI applications, using industry-specific data and expertise.

Pari uutta avointa positioita näyttäisi olevan Ouluun:                   Optomed              Engineer, Purchasing & Change Management    We are looking for a Engineer Purchasing and Change Management to join our Supply Chain team in Oulu, Finland. Apply by January 6th, 2025.         Est. reading time: 2 minutes                                                Optomed              Logistics Coordinator    We are looking for a Logistics Coordinator to join our Supply Chain team in Oulu, Finland. Apply by January 6th, 2025.         Est. reading time: 2 minutes

linkedin.com              Petri Huhtinen on LinkedIn: #aptos2024 #ai #oculomics #diabeticretinopathy...    Last week my colleague Ville Pitkänen and I visited Hong Kong to attend the #APTOS2024 symposium: Two days of excellent talks covering  various aspects of #AI…

AEYE-DS käytössä sadoissa paikoissa syyskuussa.   Eipä tuosta tiedä, että paljonko on Topconin ja paljonko Optomedin laitteita. Molemmat toimii tuon DS:n kanssa.  Luultavasti Aeye Health saa paremman katteen Aurorasta ja pyrkivät myymään sitä.

Kuka maksaa tästä raportista 4900$. Vaikka ei ostaisikaan niin tämä käsittelee kahdeksaa yritys ja niistä kaksi ovat Topcon ja Optomed. Tämäkin kertoo asian suhteen hyvää, kun yritysten määrä on nuin pieni. Kiinaksi on tämä sivu, mutta Chromehan sen kääntää. Linkki

Jaa… no ei tuossa sitten ole edes markkinaa Optomedille. Täytyy painaa kaikki laput luiskaan heti, kun kauppa aukeaa;)

Nopea googletus tarjoaa kyllä monta markkinatutkimusta, mutta maksullisia tuppaavat olemaan.  Tästä linkistä voi lukea vähän yleistä ja alempaa löytyy listaa yrityksistä laitepuolelta ja palvelupuolelta. ~150 mrd $ puuhastelua, ei sen isompaa.                   grandviewresearch.com              U.S. Home Healthcare Market Size & Share Report, 2030    The U.S. home healthcare market size was valued at USD 142.9 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 7.48% from 2023 to 2030. The Growing geriatric population and increasing prevalence of chronic diseases...

Optomed

Optomed Plc - Managers' Transactions - 12 August 2024 at 12.00 EETOptomed Plc - Managers' transactions - Myllylä____________________________________________Person subject to the notification...

Optomed Plc - Managers' Transactions - 12 August 2024 at 12.00 EETOptomed Plc - Managers' transactions - Myllylä____________________________________________Person subject to the notification requirementName: Markku MyllyläPosition: Other senior managerIssuer: Optomed OyjLEI: 7437009IVYWGEE4S7B77Notification type: INITIAL NOTIFICATIONReference number: 74101/4/4____________________________________________Transaction date: 2024-08-09Outside a trading venueInstrument type: FINANCIAL INSTRUMENT LINKED TO A SHARE OR A DEBT INSTRUMENTName of the instrument: Optomed Oyj:n optio-oikeus 2018 CNature of transaction: DISPOSAL(X) Linked to stock option programmeTransaction details(1): Volume: 60000 Unit price: 1.2756 EURAggregated transactions (1):Volume: 60000 Volume weighted average price: 1.2756 EUR

Stay up to date with our newsletter